gdc

Web Exclusives

Are Patients with Cancer Safe Around Pets?
Pet Therapy
Pets and pet therapy can bring joy to patients with cancer during a physically and emotionally draining time, but it’s important to know the risks involved.
How Virtual Learning Can Reduce Stress for Children with Cancer
COVID-19Pediatric Cancer
COVID-19 has brought virtual learning into the mainstream, meaning that a child with cancer who learns from home is now in the same “classroom” environment as any other student, which can reduce feelings of stress and anxiety.
Empowerment Through Exercise: How Physical Activity Benefits Patients with Cancer
Exercise & Cancer
Exercise has been shown to reduce the risk of a wide range of chronic diseases, and is beneficial during and after cancer treatment to maintain patients’ physical and emotional well-being.
Spreading a Vision of Love and Hope
Support Services
After the death of her brother from testicular cancer, Meg McQuarrie followed his life-affirming approach to cancer treatment by creating Elixir Fund, a nonprofit organization focused on helping patients with cancer and their caregivers.
July is UVC Safety Awareness Month
Skin CancerSlideshows
View this slideshow to learn how to protect yourself from harmful ultraviolet radiation.
How Patients with Cancer Can Get Treatment Back on Track as States Reopen
COVID-19
As states roll out their reopening plans, patients with cancer need to start scheduling treatments that have been postponed or canceled because of the COVID-19 pandemic.
Helping Others Care for You
Support ServicesSurvivorship
Mend Together: a new website connects patients with cancer with friends and family during challenging times.
Leukemia
Long-term results of a pivotal trial of acalabrutinib verify that it is effective and safe as first-line therapy for patients with chronic lymphocytic leukemia.
Leukemia
According to findings from a large clinical trial, the combination of ibrutinib and ublituximab is effective in treating patients with chronic lymphocytic leukemia.
Leukemia
The ASCEND trial confirmed that acalabrutinib, a next-generation targeted treatment, is more effective than traditional chemoimmunotherapy in patients with relapsed chronic lymphocytic leukemia.
Page 1 of 15
Results 1 - 10 of 143

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country